SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-004115
Filing Date
2021-11-10
Accepted
2021-11-10 16:31:08
Documents
61
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-20210930.htm   iXBRL 10-Q 1705036
2 EX-10.1 clsd-ex10_1.htm EX-10.1 43695
3 EX-10.2 clsd-ex10_2.htm EX-10.2 38689
4 EX-10.3 clsd-ex10_3.htm EX-10.3 23485
5 EX-31.1 clsd-ex31_1.htm EX-31.1 16794
6 EX-31.2 clsd-ex31_2.htm EX-31.2 16476
7 EX-32.1 clsd-ex32_1.htm EX-32.1 11203
8 GRAPHIC img139633814_0.jpg GRAPHIC 151569
  Complete submission text file 0000950170-21-004115.txt   6351816

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT clsd-20210930.xsd EX-101.SCH 42343
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT clsd-20210930_pre.xml EX-101.PRE 268345
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT clsd-20210930_cal.xml EX-101.CAL 35661
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT clsd-20210930_def.xml EX-101.DEF 155963
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT clsd-20210930_lab.xml EX-101.LAB 368206
14 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20210930_htm.xml XML 975504
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 211397157
SIC: 2834 Pharmaceutical Preparations